1401 related articles for article (PubMed ID: 19008712)
1. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
2. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
3. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels.
Zhu HL; Luo WQ; Wang H
Neuroscience; 2008 Dec; 157(4):884-94. PubMed ID: 18951957
[TBL] [Abstract][Full Text] [Related]
4. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
Pan Z; Huang J; Cui W; Long C; Zhang Y; Wang H
J Cardiovasc Pharmacol; 2010 Sep; 56(3):215-28. PubMed ID: 20410832
[TBL] [Abstract][Full Text] [Related]
5. A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells.
Wang H; Long C; Duan Z; Shi C; Jia G; Zhang Y
Cardiovasc Res; 2007 Feb; 73(3):497-503. PubMed ID: 17116295
[TBL] [Abstract][Full Text] [Related]
6. Uric acid: bystander or culprit in hypertension and progressive renal disease?
Menè P; Punzo G
J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
[TBL] [Abstract][Full Text] [Related]
7. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
[TBL] [Abstract][Full Text] [Related]
8. Activation of SUR2B/Kir6.1-type K(ATP) channels protects glomerular endothelial, mesangial and tubular epithelial cells against oleic acid renal damage.
Zhao Y; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):572-6. PubMed ID: 23581188
[TBL] [Abstract][Full Text] [Related]
9. A new ATP-sensitive potassium channel opener protects the kidney from hypertensive damage in spontaneously hypertensive rats.
Xue H; Zhang YL; Liu GS; Wang H
J Pharmacol Exp Ther; 2005 Nov; 315(2):501-9. PubMed ID: 16051697
[TBL] [Abstract][Full Text] [Related]
10. Iptakalim inhibited endothelin-1-induced proliferation of human pulmonary arterial smooth muscle cells through the activation of K(ATP) channel.
Zhu Y; Zhang S; Xie W; Li Q; Zhou Y; Wang H
Vascul Pharmacol; 2008; 48(2-3):92-9. PubMed ID: 18276195
[TBL] [Abstract][Full Text] [Related]
11. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.
Choi YJ; Yoon Y; Lee KY; Hien TT; Kang KW; Kim KC; Lee J; Lee MY; Lee SM; Kang DH; Lee BH
FASEB J; 2014 Jul; 28(7):3197-204. PubMed ID: 24652948
[TBL] [Abstract][Full Text] [Related]
12. Effect of elevated serum uric acid on cisplatin-induced acute renal failure.
Roncal CA; Mu W; Croker B; Reungjui S; Ouyang X; Tabah-Fisch I; Johnson RJ; Ejaz AA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F116-22. PubMed ID: 17210794
[TBL] [Abstract][Full Text] [Related]
13. Uric acid--a uremic toxin?
Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia induces endothelial dysfunction.
Khosla UM; Zharikov S; Finch JL; Nakagawa T; Roncal C; Mu W; Krotova K; Block ER; Prabhakar S; Johnson RJ
Kidney Int; 2005 May; 67(5):1739-42. PubMed ID: 15840020
[TBL] [Abstract][Full Text] [Related]
15. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
[TBL] [Abstract][Full Text] [Related]
16. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
[TBL] [Abstract][Full Text] [Related]
17. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
Zhou MS; Schulman IH; Raij L
J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
[TBL] [Abstract][Full Text] [Related]
18. The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.
Wang Y; Zeng FH; Long CL; Pan ZY; Cui WY; Wang RH; Liu GS; Wang H
Acta Pharmacol Sin; 2011 Dec; 32(12):1466-74. PubMed ID: 22056616
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
[TBL] [Abstract][Full Text] [Related]
20. The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
Assad AR; Delou JM; Fonseca LM; Villela NR; Nascimento JH; Verçosa N; Lopes AG; Capella MA
Anesth Analg; 2009 Nov; 109(5):1486-92. PubMed ID: 19843786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
